Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

February 20, 2018

Study Completion Date

February 20, 2018

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 90100 foam

Each subject has each of the 2 treatments applied at the same time on 2 different sites on the back

DRUG

Vehicle of LEO 90100 foam

Each subject has each of the 2 treatments applied at the same time on 2 different sites on the back

Trial Locations (1)

Unknown

Medical Co. LTA HAKATA clinic, Fukuoka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY